M&A, Data, & Big Approvals Are Defining Diabetes Tech in 2022
Glooko keeps the momentum going in diabetes tech by acquiring Diabnext, to expand its presence in Europe.
Glooko keeps the momentum going in diabetes tech by acquiring Diabnext, to expand its presence in Europe.